» Articles » PMID: 28779096

Quantitative Proteomics Screen Identifies a Substrate Repertoire of Rhomboid Protease RHBDL2 in Human Cells and Implicates It in Epithelial Homeostasis

Overview
Journal Sci Rep
Specialty Science
Date 2017 Aug 6
PMID 28779096
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Rhomboids are intramembrane serine proteases conserved in all kingdoms of life. They regulate epidermal growth factor receptor signalling in Drosophila by releasing signalling ligands from their transmembrane tethers. Their functions in mammals are poorly understood, in part because of the lack of endogenous substrates identified thus far. We used a quantitative proteomics approach to investigate the substrate repertoire of rhomboid protease RHBDL2 in human cells. We reveal a range of novel substrates that are specifically cleaved by RHBDL2, including the interleukin-6 receptor (IL6R), cell surface protease inhibitor Spint-1, the collagen receptor tyrosine kinase DDR1, N-Cadherin, CLCP1/DCBLD2, KIRREL, BCAM and others. We further demonstrate that these substrates can be shed by endogenously expressed RHBDL2 and that a subset of them is resistant to shedding by cell surface metalloproteases. The expression profiles and identity of the substrates implicate RHBDL2 in physiological or pathological processes affecting epithelial homeostasis.

Citing Articles

Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17.

Calligaris M, Spano D, Puccio M, Muller S, Bonelli S, Lo Pinto M Proteomics. 2024; 24(23-24):e202400076.

PMID: 39318062 PMC: 11648071. DOI: 10.1002/pmic.202400076.


Thrombomodulin (p.Cys537Stop) is released from cells by an unusual membrane insertion/leakage mechanism.

Bernard C, Pin A, Hezard N, Ernest V, Falaise C, Roze C Blood Adv. 2024; 8(21):5467-5478.

PMID: 39208365 PMC: 11532747. DOI: 10.1182/bloodadvances.2024013546.


Plasma proteomic associations with genetics and health in the UK Biobank.

Sun B, Chiou J, Traylor M, Benner C, Hsu Y, Richardson T Nature. 2023; 622(7982):329-338.

PMID: 37794186 PMC: 10567551. DOI: 10.1038/s41586-023-06592-6.


Targeting IL-6 trans-signalling: past, present and future prospects.

Rose-John S, Jenkins B, Garbers C, Moll J, Scheller J Nat Rev Immunol. 2023; 23(10):666-681.

PMID: 37069261 PMC: 10108826. DOI: 10.1038/s41577-023-00856-y.


RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.

Chen S, Cai K, Zheng D, Liu Y, Li L, He Z Cell Death Dis. 2022; 13(11):945.

PMID: 36351890 PMC: 9646733. DOI: 10.1038/s41419-022-05379-3.


References
1.
Ribatti D, Crivellato E . "Sprouting angiogenesis", a reappraisal. Dev Biol. 2012; 372(2):157-65. DOI: 10.1016/j.ydbio.2012.09.018. View

2.
Lemberg M, Freeman M . Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res. 2007; 17(11):1634-46. PMC: 2045146. DOI: 10.1101/gr.6425307. View

3.
Zhong X, Rescorla F . Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 2011; 24(2):393-401. DOI: 10.1016/j.cellsig.2011.10.005. View

4.
Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H . Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice. Am J Respir Cell Mol Biol. 2009; 42(3):286-93. DOI: 10.1165/rcmb.2008-0305OC. View

5.
Wunderle L, Knopf J, Kuhnle N, Morle A, Hehn B, Adrain C . Rhomboid intramembrane protease RHBDL4 triggers ER-export and non-canonical secretion of membrane-anchored TGFα. Sci Rep. 2016; 6:27342. PMC: 4893610. DOI: 10.1038/srep27342. View